Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity 
 
Major Surgical or Invasive Procedure:
Laparoscopic sleeve gastrectomy 

 
History of Present Illness:
 She is a ___
woman complaining of obesity since age ___ and delivery of her
twin babies at that time.  Since then, she has been on multiple
supervised diets with a maximum 50-pound weight loss and regain. 

I reviewed the OMR note from Dr. ___ in the ___
Bariatric Program from ___, recommending her for
weight loss surgery.

 
Past Medical History:
Past Medical History:  Includes type 2 diabetes with 
nephropathy,
hyperlipidemia, PID, vitamin B12 deficiency, vitamin D
deficiency.

Past Surgical History:  Status post C-section, status post tubal
ligation and status post breast reduction.

 
Social History:
___
Family History:
Mother overweight, works in ___ service.

 
Physical Exam:
Discharge Physical Exam:  
VS: 99.6 120/77 85 16 97%RA  
GEN: AA&O x 3, NAD, calm, cooperative.  
HEENT: (-)LAD, mucous membranes moist, trachea midline, EOMI  
CHEST: Clear to auscultation bilaterally, (-) cyanosis.  
ABDOMEN: soft, diffuse tenderness, incision sites are c/d/i 
covered with steri-strips  
EXTREMITIES: Warm, well perfused, no edema  

 
Pertinent Results:
___ 11:25AM   HCT-37.3
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia.  
The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.  
Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
GI/GU/FEN: The patient was initially kept NPO. As a result, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.  
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 160 mg/5 mL 650 mg by mouth every six (6) 
hours Refills:*0 
2.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every four (4) hours 
Refills:*0 
3.  Ranitidine (Liquid) 150 mg PO BID 
RX *ranitidine HCl 15 mg/mL 150 mg by mouth twice a day 
Refills:*0 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid Obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Please call your surgeon or return to the emergency department 
if you develop a fever greater than 101.5, chest pain, shortness 
of breath, severe abdominal pain, pain unrelieved by your pain 
medication, severe nausea or vomiting, severe abdominal 
bloating, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness or swelling around your 
incisions, or any other symptoms which are concerning to you.  

Diet: Stay on Stage III diet until your follow up appointment. 
Do not self advance diet, do not drink out of a straw or chew 
gum  
Resume your home medications, CRUSH ALL PILLS.  

You will be starting some new medications:  
1. You are being discharged on medications to treat the pain  
from your operation. These medications will make you drowsy and  

impair your ability to drive a motor vehicle or operate  
machinery safely. 
You MUST refrain from such activities while taking these 
medications.  
2. You should begin taking a chewable complete multivitamin with 
 
minerals. No gummy vitamins.  
3. You will be taking Zantac liquid ___ mg twice daily for one  
month. This medicine prevents gastric reflux.  
4. You should take a stool softener, Colace, twice daily for  
constipation as needed, or until you resume a normal bowel  
pattern.  
5. You must not use NSAIDS (non-steroidal anti-inflammatory  
drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and  
Naproxen. These agents will cause bleeding and ulcers in your  
digestive system.  

Activity:  
No heavy lifting of items ___ pounds for 6 weeks. You may  
resume moderate exercise at your discretion, no abdominal  
exercises.  

Wound Care:  
You may shower, no tub baths or swimming.  
If there is clear drainage from your incisions, cover with  
clean, dry gauze.  
Your steri-strips will fall off on their own. Please remove any  

remaining strips ___ days after surgery.  
Please call the doctor if you have increased pain, swelling,  
redness, or drainage from the incision sites. 
 
Followup Instructions:
___